These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2486483)

  • 1. Treatment of recurrent and metastatic carcinoma of cervix: a comparison of low dose methotrexate with adriamycin plus methotrexate.
    Sabir AA; Khoury GG; Joslin CA; Head C
    Clin Oncol (R Coll Radiol); 1989 Nov; 1(2):70-4. PubMed ID: 2486483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of recurrent and metastatic cervical carcinoma. Evaluation of an antiblastic combination of methotrexate-adriamycin-bleomycin (MAB).
    Adamo V; Altavilla G; Buemi B; Caristi N; Scalisi R; Tropea F
    Chemioterapia; 1985 Apr; 4(2):143-6. PubMed ID: 2408771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix.
    Haid M; Homesley HL; White DR; Cooper MR; Richards F; Muss HB; Spurr CL
    Obstet Gynecol; 1977 Jul; 50(1):103-5. PubMed ID: 876513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer.
    Wheelock JB; Krebs HB; Goplerud DR; Myers M
    Obstet Gynecol; 1985 Sep; 66(3):410-2. PubMed ID: 4040622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
    J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.
    Long HJ; Cross WG; Wieand HS; Webb MJ; Mailliard JA; Kugler JW; Tschetter LK; Kardinal CG; Ebbert LP; Rayson S
    Gynecol Oncol; 1995 May; 57(2):235-9. PubMed ID: 7729741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature.
    Long HJ; Rayson S; Podratz KC; Abu-Ghazaleh S; Suman V; Hartmann LC; Levitt R; Nair S; Hatfield AK; Knost JA
    Am J Clin Oncol; 2002 Dec; 25(6):547-51. PubMed ID: 12477995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix.
    Papadimitriou CA; Dimopoulos MA; Giannakoulis N; Sarris K; Vassilakopoulos G; Akrivos T; Voulgaris Z; Vlahos G; Diakomanolis E; Michalas S
    Cancer; 1997 Jun; 79(12):2391-5. PubMed ID: 9191528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer.
    Eisenberger M; Krasnow S; Ellenberg S; Silva H; Abrams J; Sinibaldi V; Van Echo D; Aisner J
    J Clin Oncol; 1989 Sep; 7(9):1341-5. PubMed ID: 2671289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix: a third look.
    Tropé C; Johnsson JE; Grundsell H; Mattsson W
    Obstet Gynecol; 1980 Apr; 55(4):488-92. PubMed ID: 7366905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomised trial comparing hydroxyurea with cisdiamminedichloro-platinum plus methotrexate.
    Bezwoda WR; Nissenbaum M; Derman DP
    Med Pediatr Oncol; 1986; 14(1):17-9. PubMed ID: 3512970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study.
    Long HJ; Monk BJ; Huang HQ; Grendys EC; McMeekin DS; Sorosky J; Miller DS; Eaton LA; Fiorica JV;
    Gynecol Oncol; 2006 Mar; 100(3):537-43. PubMed ID: 16216315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix.
    Guthrie D; Way S
    Obstet Gynecol; 1981 May; 57(5):677-8. PubMed ID: 7219919
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
    Aisner J; Cirrincione C; Perloff M; Perry M; Budman D; Abrams J; Panasci L; Muss H; Citron M; Holland J
    J Clin Oncol; 1995 Jun; 13(6):1443-52. PubMed ID: 7751891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
    Pouessel D; Chevret S; Rolland F; Gravis G; Geoffrois L; Roubaud G; Terrisse S; Boyle H; Chevreau C; Dauba J; Moriceau G; Alexandre I; Deplanque G; Chapelle A; Vauleon E; Colau A; Audenet F; Grellety T; Culine S
    Eur J Cancer; 2016 Feb; 54():69-74. PubMed ID: 26724422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio.
    Legha SS; Ajani JA; Blumenschein GR; Hortobagyi GN; Buzdar AU
    Cancer; 1984 May; 53(9):1836-40. PubMed ID: 6231092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck.
    Colella E; Merlano M; Blengio F; Angelini F; Ausili Cefaro GP; Scasso F; Lo Russo V; Cirulli S; Giannarelli D; Cognetti F
    Eur J Cancer; 1994; 30A(7):928-30. PubMed ID: 7946585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleomycin, vincristine, and methotrexate with citrovorum factor rescue in the treatment of advanced squamous cell carcinoma of the cervix.
    Hannigan EV; Dillard EA; Dinh TV
    Gynecol Oncol; 1984 Sep; 19(1):57-9. PubMed ID: 6205946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.